Search

Displaying results 5601 - 5610 of 10000 in total
  1. Drug

    TRV-120027

    go.drugbank.com/drugs/DB12199
    Investigational

    TRV120027 has been used in trials studying the treatment of Heart Failure and Kidney Disease.

  2. Drug

    GDC-0917

    go.drugbank.com/drugs/DB12336
    Investigational

    CUDC-427 has been used in trials studying the treatment of LYMPHOMA and Solid Cancers.

  3. Drug

    Zamicastat

    go.drugbank.com/drugs/DB12389
    Investigational

    Zamicastat has been used in trials studying the treatment of Hypertension and Chronic Heart Failure.

  4. Drug

    Decernotinib

    go.drugbank.com/drugs/DB12566
    Investigational

    Decernotinib has been used in trials studying the treatment of Drug Interactions and Rheumatoid Arthritis.

  5. Drug

    Piperine

    go.drugbank.com/drugs/DB12582
    Investigational

    Bioperine has been used in trials studying the treatment of Multiple Myeloma and Deglutition Disorders.

  6. Drug

    Salirasib

    go.drugbank.com/drugs/DB12681
    Investigational

    Salirasib has been used in trials studying the diagnostic of Carcinoma, Non-Small-Cell Lung.

  7. Drug

    UK-432097

    go.drugbank.com/drugs/DB12691
    Investigational

    UK-432,097 has been used in trials studying the treatment of Pulmonary Disease, Chronic Obstructive.

  8. Drug

    Vintafolide

    go.drugbank.com/drugs/DB05168
    Investigational

    Vintafolide is a folate-targeted chemotherapeutic conjugate (folate vitamin + vinca alkaloid) in clinical stage development as a treatment for folate-receptor positive cancers.

  9. Drug

    Navitoclax

    go.drugbank.com/drugs/DB12340
    Investigational

    Navitoclax has been used in trials studying the treatment and basic science of Solid Tumors, Non-Hodgkin's Lymphoma, EGFR Activating Mutation, Chronic Lymphoid Leukemia, and Hematological Malignancies, … Navitoclax is an orally bioavailable small molecule inhibitor of Bcl-2 family proteins. It is a substance being studied in the treatment of lymphomas and other types of cancer.

    Synonyms: (R)-4-(3-Morpholin-4-Yl-1-Phenylsulfanylmethyl-Propylamino)-N-(4-{4-[2-(4-Chlorophenyl)-5,5-Dimethylcyclohex-1-Enylmethyl]-Piperazin-1-Yl}-Benzoyl)-3-Trifluoromethanesulfonylbenzenesulfonamide
  10. Drug

    Padoprazan

    go.drugbank.com/drugs/DB21689
    Experimental

    The usage of the INN stem '-prazan' in the name indicates that Padoprazan is a proton pump inhibitor, not dependent on acid activation. Padoprazan has a monoisotopic molecular weight of 405.12 Da.